[1]
T. A. Faunce, K. Johnston, and H. Bambrick, “The Trans-Tasman Therapeutic Products Authority: Potential AUSFTA Impacts on Safety and Cost-Effectiveness Regulation for Medicines and Medical Devices in New Zealand”, VUWLR, vol. 37, no. 3, pp. 365–390, Sep. 2006.